L R Dougherty1, V C Smith1, S J Bufferd2, E M Kessel3, G A Carlson4, D N Klein3. 1. Department of Psychology,University of Maryland College Park,College Park State,MD,USA. 2. Department of Psychology,California State University San Marcos,San Marcos,CA,USA. 3. Department of Psychology,Stony Brook University,Stony Brook,NY,USA. 4. Department of Psychiatry,Stony Brook School of Medicine,Stony Brook,NY,USA.
Abstract
BACKGROUND: Little is known about the predictive validity of disruptive mood dysregulation disorder (DMDD). This longitudinal, community-based study examined associations of DMDD at the age of 6 years with psychiatric disorders, functional impairment, peer functioning and service use at the age of 9 years. METHOD: A total of 473 children were assessed at the ages of 6 and 9 years. Child psychopathology and functional impairment were assessed at the age of 6 years with the Preschool Age Psychiatric Assessment with parents and at the age of 9 years with the Kiddie-Schedule of Affective Disorders and Schizophrenia (K-SADS) with parents and children. At the age of 9 years, mothers, fathers and youth completed the Child Depression Inventory (CDI) and the Screen for Child Anxiety Related Disorders, and teachers and K-SADS interviewers completed measures of peer functioning. Significant demographic covariates were included in all models. RESULTS: DMDD at the age of 6 years predicted a current diagnosis of DMDD at the age of 9 years. DMDD at the age of 6 years also predicted current and lifetime depressive disorder and attention-deficit/hyperactivity disorder (ADHD) at the age of 9 years, after controlling for all age 6 years psychiatric disorders. In addition, DMDD predicted depressive, ADHD and disruptive behavior disorder symptoms on the K-SADS, and maternal and paternal reports of depressive symptoms on the CDI, after controlling for the corresponding symptom scale at the age of 6 years. Last, DMDD at the age of 6 years predicted greater functional impairment, peer problems and educational support service use at the age of 9 years, after controlling for all psychiatric disorders at the age of 6 years. CONCLUSIONS: Children with DMDD are at high risk for impaired functioning across childhood, and this risk is not accounted for by co-morbid conditions.
BACKGROUND: Little is known about the predictive validity of disruptive mood dysregulation disorder (DMDD). This longitudinal, community-based study examined associations of DMDD at the age of 6 years with psychiatric disorders, functional impairment, peer functioning and service use at the age of 9 years. METHOD: A total of 473 children were assessed at the ages of 6 and 9 years. Childpsychopathology and functional impairment were assessed at the age of 6 years with the Preschool Age Psychiatric Assessment with parents and at the age of 9 years with the Kiddie-Schedule of Affective Disorders and Schizophrenia (K-SADS) with parents and children. At the age of 9 years, mothers, fathers and youth completed the ChildDepression Inventory (CDI) and the Screen for ChildAnxiety Related Disorders, and teachers and K-SADS interviewers completed measures of peer functioning. Significant demographic covariates were included in all models. RESULTS:DMDD at the age of 6 years predicted a current diagnosis of DMDD at the age of 9 years. DMDD at the age of 6 years also predicted current and lifetime depressive disorder and attention-deficit/hyperactivity disorder (ADHD) at the age of 9 years, after controlling for all age 6 years psychiatric disorders. In addition, DMDD predicted depressive, ADHD and disruptive behavior disorder symptoms on the K-SADS, and maternal and paternal reports of depressive symptoms on the CDI, after controlling for the corresponding symptom scale at the age of 6 years. Last, DMDD at the age of 6 years predicted greater functional impairment, peer problems and educational support service use at the age of 9 years, after controlling for all psychiatric disorders at the age of 6 years. CONCLUSIONS:Children with DMDD are at high risk for impaired functioning across childhood, and this risk is not accounted for by co-morbid conditions.
Authors: Melissa A Brotman; Mariana Schmajuk; Brendan A Rich; Daniel P Dickstein; Amanda E Guyer; E Jane Costello; Helen L Egger; Adrian Angold; Daniel S Pine; Ellen Leibenluft Journal: Biol Psychiatry Date: 2006-11-01 Impact factor: 13.382
Authors: Ellen Leibenluft; Patricia Cohen; Tristan Gorrindo; Judith S Brook; Daniel S Pine Journal: J Child Adolesc Psychopharmacol Date: 2006-08 Impact factor: 2.576
Authors: Nancy E Adleman; Reilly Kayser; Daniel Dickstein; R James R Blair; Daniel Pine; Ellen Leibenluft Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-09-09 Impact factor: 8.829
Authors: B Birmaher; D A Brent; L Chiappetta; J Bridge; S Monga; M Baugher Journal: J Am Acad Child Adolesc Psychiatry Date: 1999-10 Impact factor: 8.829
Authors: Amanda E Guyer; Erin B McClure; Abby D Adler; Melissa A Brotman; Brendan A Rich; Alane S Kimes; Daniel S Pine; Monique Ernst; Ellen Leibenluft Journal: J Child Psychol Psychiatry Date: 2007-09 Impact factor: 8.982
Authors: Argyris Stringaris; Helena Zavos; Ellen Leibenluft; Barbara Maughan; Thalia C Eley Journal: Am J Psychiatry Date: 2011-10-31 Impact factor: 18.112
Authors: Jillian Lee Wiggins; Margaret J Briggs-Gowan; Ryne Estabrook; Melissa A Brotman; Daniel S Pine; Ellen Leibenluft; Lauren S Wakschlag Journal: J Am Acad Child Adolesc Psychiatry Date: 2017-12-28 Impact factor: 8.829
Authors: Lea R Dougherty; Chelsey S Barrios; Gabrielle A Carlson; Daniel N Klein Journal: J Child Adolesc Psychopharmacol Date: 2017-02-17 Impact factor: 2.576
Authors: Alecia C Vogel; Rebecca Tillman; Nourhan M El-Sayed; Joshua J Jackson; Susan B Perlman; Deanna M Barch; Joan L Luby Journal: Dev Psychopathol Date: 2021-12-07
Authors: Megan C Finsaas; Ellen M Kessel; Lea R Dougherty; Sara J Bufferd; Allison P Danzig; Joanne Davila; Gabrielle A Carlson; Daniel N Klein Journal: J Clin Child Adolesc Psychol Date: 2018-10-11